This article is more than 5 years old. Information may no longer be current.
PSA screening rate unchanged among older men
The rate at which men aged 65 years and older underwent PSA screening remained consistent between 2005 and 2010, according to study results.
One-third of older men with a high likelihood of 9-year mortality underwent screening despite the anticipated lack of clinical benefit, researchers found.
Michael W. Drazer, PhD, of the University of Chicago Medical Center, and colleagues analyzed data from the 2005 and 2010 National Health Interview Surveys to compare the proportions of men who reported undergoing PSA screening in the previous year.
Results showed PSA screening rates among men aged ≥65 years remained the same (48%) in both surveys (P=.9).
Logistic regression showed men aged 65 to 74 years, who had a predicted 9-year mortality rate of less than 27%, were the most commonly screened group. In 2010, the screening rate among that group was 56%, compared with 34% for men aged ≥75 years, who had a predicted 9-year mortality rate >75%.
Results showed 55% of men aged ≥75 years who underwent screening recalled speaking with a clinician about the advantages of PSA screening, whereas only 25% of those men recalled talking about the disadvantages of screening.
Given the controversy surrounding PSA screening, the findings demonstrate the need for shared decision-making, the researchers concluded.
Disclosure: HemOnc Today could not confirm relevant financial disclosures at the time of publication.